| dc.creator | Spanos K., Nicolaides A.N., Giannoukas A.D. | en |
| dc.date.accessioned | 2023-01-31T10:00:42Z | |
| dc.date.available | 2023-01-31T10:00:42Z | |
| dc.date.issued | 2016 | |
| dc.identifier | 10.1016/j.ejvs.2016.05.034 | |
| dc.identifier.issn | 10785884 | |
| dc.identifier.uri | http://hdl.handle.net/11615/79293 | |
| dc.description.abstract | [No abstract available] | en |
| dc.language.iso | en | en |
| dc.source | European Journal of Vascular and Endovascular Surgery | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978537446&doi=10.1016%2fj.ejvs.2016.05.034&partnerID=40&md5=40e1be9e8755d167d25b0f251326411e | |
| dc.subject | antihypertensive agent | en |
| dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | en |
| dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | en |
| dc.subject | antihypertensive therapy | en |
| dc.subject | asymptomatic disease | en |
| dc.subject | cardiovascular risk | en |
| dc.subject | carotid artery obstruction | en |
| dc.subject | human | en |
| dc.subject | Letter | en |
| dc.subject | mortality | en |
| dc.subject | practice guideline | en |
| dc.subject | priority journal | en |
| dc.subject | risk reduction | en |
| dc.subject | angioplasty | en |
| dc.subject | carotid endarterectomy | en |
| dc.subject | Carotid Stenosis | en |
| dc.subject | risk factor | en |
| dc.subject | Stroke | en |
| dc.subject | Angioplasty | en |
| dc.subject | Carotid Stenosis | en |
| dc.subject | Endarterectomy, Carotid | en |
| dc.subject | Humans | en |
| dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors | en |
| dc.subject | Risk Factors | en |
| dc.subject | Stroke | en |
| dc.subject | W.B. Saunders Ltd | en |
| dc.title | Re: ‘Long-term Mortality in Patients with Asymptomatic Carotid Stenosis: Implications for Statin Therapy’ | en |
| dc.type | other | en |